168 related articles for article (PubMed ID: 9807580)
1. Breast disease: dynamic spiral MR imaging.
Daniel BL; Yen YF; Glover GH; Ikeda DM; Birdwell RL; Sawyer-Glover AM; Black JW; Plevritis SK; Jeffrey SS; Herfkens RJ
Radiology; 1998 Nov; 209(2):499-509. PubMed ID: 9807580
[TBL] [Abstract][Full Text] [Related]
2. Primary breast abnormalities: selective pixel sampling on dynamic gadolinium-enhanced MR images.
Mussurakis S; Gibbs P; Horsman A
Radiology; 1998 Feb; 206(2):465-73. PubMed ID: 9457201
[TBL] [Abstract][Full Text] [Related]
3. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
Kuhl CK; Schild HH; Morakkabati N
Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
[TBL] [Abstract][Full Text] [Related]
4. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
6. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
[TBL] [Abstract][Full Text] [Related]
7. Benign and malignant breast lesions: diagnosis with multiparametric MR imaging.
Jacobs MA; Barker PB; Bluemke DA; Maranto C; Arnold C; Herskovits EH; Bhujwalla Z
Radiology; 2003 Oct; 229(1):225-32. PubMed ID: 14519877
[TBL] [Abstract][Full Text] [Related]
8. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
[TBL] [Abstract][Full Text] [Related]
9. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
Choi N; Han BK; Choe YH; Kim HS
J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
[TBL] [Abstract][Full Text] [Related]
10. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation.
Fobben ES; Rubin CZ; Kalisher L; Dembner AG; Seltzer MH; Santoro EJ
Radiology; 1995 Jul; 196(1):143-52. PubMed ID: 7784558
[TBL] [Abstract][Full Text] [Related]
11. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.
Boetes C; Barentsz JO; Mus RD; van der Sluis RF; van Erning LJ; Hendriks JH; Holland R; Ruys SH
Radiology; 1994 Dec; 193(3):777-81. PubMed ID: 7972823
[TBL] [Abstract][Full Text] [Related]
12. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
13. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T].
Fischer U; Westerhof JP; Brinck U; Korabiowska M; Schauer A; Grabbe E
Rofo; 1996 Apr; 164(4):290-4. PubMed ID: 8645861
[TBL] [Abstract][Full Text] [Related]
14. Peripheral washout sign on contrast-enhanced MR images of the breast.
Sherif H; Mahfouz AE; Oellinger H; Hadijuana J; Blohmer JU; Taupitz M; Felix R; Hamm B
Radiology; 1997 Oct; 205(1):209-13. PubMed ID: 9314987
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ: MR imaging-histopathologic correlation.
Gilles R; Zafrani B; Guinebretière JM; Meunier M; Lucidarme O; Tardivon AA; Rochard F; Vanel D; Neuenschwander S; Arriagada R
Radiology; 1995 Aug; 196(2):415-9. PubMed ID: 7617854
[TBL] [Abstract][Full Text] [Related]
16. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
Nishiura M; Yasuhiro T; Murase K
Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience.
Kuhl CK; Jost P; Morakkabati N; Zivanovic O; Schild HH; Gieseke J
Radiology; 2006 Jun; 239(3):666-76. PubMed ID: 16549623
[TBL] [Abstract][Full Text] [Related]
19. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer.
Espinosa LA; Daniel BL; Vidarsson L; Zakhour M; Ikeda DM; Herfkens RJ
Radiology; 2005 Nov; 237(2):429-36. PubMed ID: 16244250
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of clinical breast MR imaging performed with prototype computer-aided diagnosis breast MR imaging workstation: reader study.
Shimauchi A; Giger ML; Bhooshan N; Lan L; Pesce LL; Lee JK; Abe H; Newstead GM
Radiology; 2011 Mar; 258(3):696-704. PubMed ID: 21212365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
